Trial Profile
Evaluation of efficacy of rebamipide ophthalmic suspension in treatment of keratoconjunctivitis sicca (KCS) in patients with Sjogren syndrome (SS) with or without punctal occlusions
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Keratoconjunctivitis sicca; Sjogren's syndrome
- Focus Therapeutic Use
- 06 Dec 2015 New trial record